Novartis puts record in options market as shorts add pressure

The put-call ratio on NVS hit 2.69 on November 2, the highest reading in 52 weeks and 3.3 standard deviations above the 20-day mean of 2.06. That is a meaningful jump from a PCR that had sat between 1.79 and 2.32 for most of October, and it arrives alongside a short book that has grown 10% in a single week.

Why this matters: These signals are moving in the same direction at the same time, one week after Q3 earnings. The options market has not shown this degree of put-heavy positioning in at least a year, and Deutsche Bank's fresh Sell rating gives that positioning a fundamental anchor.

Options lead, shorts follow

The PCR move is the freshest data point and the sharpest. At 2.69, puts outnumber calls by nearly three to one. The prior 52-week range ran from 0.74 to 2.21 before this week's reading broke through. A z-score of 3.3 places this well outside the normal distribution of NVS options activity.

The short book is moving in the same direction. Shares short reached 5.93 million as of October 30, up 10% on the week. Cost to borrow nearly doubled over the same period, to 0.50%. That said, availability in the lending pool stands at 712%, still deep enough that there is no mechanical squeeze risk. Seven shares remain available for every one currently borrowed.

Deutsche Bank: still the lone Sell

Deutsche Bank downgraded NVS to Sell from Hold on October 30, the first outright bearish rating from a major bank since Goldman Sachs cut to Sell in September 2025. The stock gained 3.2% on the day of the downgrade. It has since added a further 0.5%, closing November 2 at $161.52, up 14.6% over the past month.

Four of the five tracked analysts still rate NVS at Buy or equivalent. Morgan Stanley maintains Overweight with a $170 target. HSBC upgraded to Hold in September. Deutsche Bank is alone on the bearish side. Consensus implies roughly 12% upside from current levels.

That disconnect, a stock near its recent highs with a surging put ratio and a growing short book, is the tension worth watching. The options market is pricing in more downside risk than the analyst consensus acknowledges.

Institutional register stable

BlackRock disclosed a 7.1% stake in an October 27 filing, the most recent on record. UBS Asset Management holds 6.4% as last disclosed in July 2025. These are passive 13G filings and carry no activist intent; stakes are as last disclosed and holders crossing below 5% may not file again.

Massachusetts Financial Services added 2.93 million shares in its most recent reported period, the largest absolute addition among tracked holders.

---

• Next earnings: February 3, 2027
• What to watch: Whether the PCR holds above 2.0 into year-end, and whether any further analyst firms follow Deutsche Bank's move to Sell before the Q4 print.